Watchlist Price Alert

Climb Bio Inc. (CLYM)

NASDAQ: CLYM · Real-Time Price · USD

1.41

0.02 (1.44%)

At close: Jun 09, 2025, 10:03 AM

Climb Bio Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-82.02M	-76.23M	-69.5M	-19.84M	-40.27M	-44.71M	-48.45M	-55.44M	-45.13M	-46.28M	-46.92M	-41.92M	-35.67M	-40.08M	-32.95M	-25.85M	-20.93M	-5.82M	-3.56M	-1.95M
Interest Income	1.34M	2.69M	3.95M	3.95M	3.51M	2.16M	1.28M	1.28M	383K	383K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-73.9M	-69.12M	-64.19M	-14.53M	-35.12M	-39.24M	-44.95M	-54.33M	-45.24M	-48.03M	-47.96M	-42.08M	-47.48M	-51.8M	-44.44M	-37.35M	-20.67M	-5.8M	-3.55M	-1.92M
Net Income	-73.9M	-69.12M	-64.19M	-14.53M	-35.12M	-39.24M	-44.95M	-54.33M	-45.24M	-48.03M	-47.96M	-42.08M	-47.48M	-51.8M	-44.44M	-37.35M	-20.67M	-5.8M	-3.55M	-1.92M
Selling & General & Admin	16.02M	13.07M	9.7M	9.06M	24.86M	27.5M	29.86M	31.77M	18.92M	18.12M	17.02M	15M	12.35M	10.06M	6.98M	4.32M	2.42M	888K	576K	328K
Research & Development	66M	63.16M	59.8M	10.78M	15.41M	17.21M	18.59M	23.67M	26.21M	28.17M	29.9M	26.92M	23.32M	20.86M	16.81M	12.38M	9.34M	4.93M	2.98M	1.62M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.16M	9.16M	9.16M	9.16M	n/a	n/a	n/a
Operating Expenses	82.02M	76.23M	69.5M	19.84M	40.27M	44.71M	48.45M	55.44M	45.13M	46.28M	46.92M	41.92M	35.67M	40.08M	32.95M	25.85M	20.93M	5.82M	3.56M	1.95M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	82.02M	76.23M	69.5M	19.84M	40.27M	44.71M	48.45M	55.44M	45.13M	46.28M	46.92M	41.92M	35.67M	40.08M	32.95M	25.85M	20.93M	5.82M	3.56M	1.95M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	64.74M	67.01M	30.35M	27.64M	27.31M	27.07M	26.84M	26.54M	26.37M	26.34M	26.3M	26.24M	26.23M	15.59M	23.46M	11.66M	n/a	11.66M	11.66M	11.66M
Shares Outstanding (Diluted)	64.74M	67.01M	30.35M	27.64M	27.31M	27.07M	26.84M	26.54M	26.37M	26.34M	26.3M	26.24M	26.23M	15.59M	23.46M	11.66M	n/a	11.66M	11.66M	11.66M
EPS (Basic)	-2.13	-2.13	-2.15	-0.53	-1.31	-1.47	-1.69	-2.06	-1.72	-1.83	-2.16	-2.06	-3.25	-2.85	-2.38	-2.1	-0.61	-0.61	-0.38	-0.2
EPS (Diluted)	-2.13	-2.13	-2.15	-0.53	-1.31	-1.47	-1.69	-2.06	-1.72	-1.83	-2.16	-2.06	-3.25	-2.85	-2.38	-2.1	-0.61	-0.61	-0.38	-0.2
EBITDA	-82.02M	-76.23M	-69.5M	-19.84M	-40.27M	-44.71M	-48.45M	-55.44M	-45.13M	-46.28M	-46.92M	-41.92M	-35.67M	-30.92M	-23.79M	-16.7M	-11.77M	-5.82M	-3.56M	-1.95M
EBIT	-82.02M	-76.23M	-69.5M	-19.84M	-40.27M	-44.71M	-48.45M	-55.44M	-45.13M	-46.28M	-46.92M	-41.92M	-35.67M	-30.92M	-23.79M	-16.7M	-11.77M	-5.82M	-3.56M	-1.95M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a